• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类胰腺疾病中CD39/核苷三磷酸二磷酸酶和P2受体的上调

Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease.

作者信息

Künzli Beat M, Berberat Pascal O, Giese Thomas, Csizmadia Eva, Kaczmarek Elzbieta, Baker Colin, Halaceli Irfan, Büchler Markus W, Friess Helmut, Robson Simon C

机构信息

Liver and Transplantation Centers, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, 02215, USA.

出版信息

Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G223-30. doi: 10.1152/ajpgi.00259.2006. Epub 2006 Aug 17.

DOI:10.1152/ajpgi.00259.2006
PMID:16920697
Abstract

Chronic inflammation, fibrosis, atrophy, malignant transformation, and thromboembolic events are hallmarks of chronic pancreatic disease. Extracellular nucleotides have been implicated as inflammatory mediators in many pathological situations. However, there are minimal data detailing expression of ectonucleotidases and type-2 purinergic receptors (P2R) in chronic pancreatitis and pancreatic cancer. We have therefore defined tissue distribution and localization of the CD39 family of ectonucleotidases and associated P2R in human disease. Transcripts of ectonucleotidases (CD39 and CD39L1) together with P2R (P2X7, P2Y2, and P2Y6) are significantly increased in both chronic pancreatitis and pancreatic cancer. CD39 and CD39L1 are preferentially associated with the vasculature and stromal elements in pathological tissues. P2X7 mRNA upregulation was associated with chronic pancreatitis, and heightened protein expression was found to be localized to infiltrating cells. P2Y2 was markedly upregulated in biopsies of pancreatic cancer tissues and expressed by fibroblasts adjacent to tumors. High-tissue mRNA levels of CD39 significantly correlated with better long-term survival after tumor resection in patients with pancreatic cancer. Heightened expression patterns and localization patterns of CD39, P2X7, and P2Y2 infer associations with chronic inflammation and neoplasia of the pancreas. Our data suggest distinct roles for CD39 and P2-purinergic signaling in both tissue remodeling and fibrogenesis with respect to human pancreatic diseases.

摘要

慢性炎症、纤维化、萎缩、恶性转化和血栓栓塞事件是慢性胰腺疾病的特征。细胞外核苷酸在许多病理情况下被认为是炎症介质。然而,关于外核苷酸酶和2型嘌呤能受体(P2R)在慢性胰腺炎和胰腺癌中表达的详细数据很少。因此,我们确定了人类疾病中外核苷酸酶CD39家族及其相关P2R的组织分布和定位。在慢性胰腺炎和胰腺癌中,外核苷酸酶(CD39和CD39L1)以及P2R(P2X7、P2Y2和P2Y6)的转录本均显著增加。CD39和CD39L1在病理组织中优先与脉管系统和基质成分相关。P2X7 mRNA上调与慢性胰腺炎相关,且发现其蛋白表达增强定位于浸润细胞。P2Y2在胰腺癌组织活检中显著上调,并由肿瘤邻近的成纤维细胞表达。胰腺癌患者肿瘤切除后,CD39的高组织mRNA水平与更好的长期生存率显著相关。CD39、P2X7和P2Y2的表达模式和定位模式增强表明它们与胰腺的慢性炎症和肿瘤形成有关。我们的数据表明,CD39和P2-嘌呤能信号在人类胰腺疾病的组织重塑和纤维化形成中具有不同作用。

相似文献

1
Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease.人类胰腺疾病中CD39/核苷三磷酸二磷酸酶和P2受体的上调
Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G223-30. doi: 10.1152/ajpgi.00259.2006. Epub 2006 Aug 17.
2
Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.CD39基因敲除小鼠的胰腺炎症反应紊乱及纤维化抑制
Gastroenterology. 2008 Jan;134(1):292-305. doi: 10.1053/j.gastro.2007.10.030. Epub 2007 Oct 25.
3
Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.CD39家族的外核苷酸酶调节移植中的血管炎症和血栓形成。
Semin Thromb Hemost. 2005 Apr;31(2):217-33. doi: 10.1055/s-2005-869527.
4
Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.CD39基因敲除小鼠中的自然杀伤T细胞功能障碍可预防伴刀豆球蛋白A诱导的肝炎。
Hepatology. 2008 Sep;48(3):841-52. doi: 10.1002/hep.22401.
5
CD39+ regulatory T cells attenuate allergic airway inflammation.CD39+ 调节性 T 细胞可减轻过敏性气道炎症。
Clin Exp Allergy. 2015 Jun;45(6):1126-37. doi: 10.1111/cea.12521.
6
Co-localization of P2Y1 receptor and NTPDase1/CD39 within caveolae in human placenta.人胎盘小窝内P2Y1受体与NTPDase1/CD39的共定位
Eur J Histochem. 2004 Jul-Sep;48(3):253-9.
7
CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.CD39 限制 P2X7 受体炎症信号转导,减轻脓毒症引起的肝损伤。
J Hepatol. 2017 Oct;67(4):716-726. doi: 10.1016/j.jhep.2017.05.021. Epub 2017 May 26.
8
Purinergic Signaling in Pancreas-From Physiology to Therapeutic Strategies in Pancreatic Cancer.嘌呤能信号在胰腺中的作用——从生理学角度到胰腺癌的治疗策略。
Int J Mol Sci. 2020 Nov 20;21(22):8781. doi: 10.3390/ijms21228781.
9
Purinergic signaling during intestinal inflammation.嘌呤能信号在肠道炎症中的作用。
J Mol Med (Berl). 2017 Sep;95(9):915-925. doi: 10.1007/s00109-017-1545-1. Epub 2017 May 26.
10
NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.NTPDase1/CD39 和 COPD 发病机制中的嘌呤能信号异常。
Eur Respir J. 2016 Jan;47(1):254-63. doi: 10.1183/13993003.02144-2014. Epub 2015 Nov 5.

引用本文的文献

1
Extracellular Adenosine in Gastric Cancer: The Role of GCSCs.胃癌中的细胞外腺苷:胃肿瘤干细胞的作用
Int J Mol Sci. 2025 Aug 6;26(15):7594. doi: 10.3390/ijms26157594.
2
Prognostic model development using novel genetic signature associated with adenosine metabolism and immune status for patients with hepatocellular carcinoma.利用与腺苷代谢和免疫状态相关的新型基因特征为肝细胞癌患者开发预后模型。
J Physiol Biochem. 2025 Feb;81(1):157-172. doi: 10.1007/s13105-024-01061-8. Epub 2024 Nov 15.
3
Unlocking antitumor immunity with adenosine receptor blockers.
用腺苷受体阻滞剂开启抗肿瘤免疫。
Cancer Drug Resist. 2023 Oct 25;6(4):748-767. doi: 10.20517/cdr.2023.63. eCollection 2023.
4
Immunological role and clinical prognostic significance of P2RY6 in lung adenocarcinoma: a multi-omics studies and single-cell sequencing analysis.P2RY6 在肺腺癌中的免疫作用和临床预后意义:多组学研究和单细胞测序分析。
World J Surg Oncol. 2023 Oct 26;21(1):341. doi: 10.1186/s12957-023-03216-1.
5
CD39 molecule: a negative regulator expressed on T cells in patients with lung adenocarcinoma.CD39分子:肺腺癌患者T细胞上表达的负性调节因子
Arch Med Sci. 2023 Aug 25;19(5):1558-1563. doi: 10.5114/aoms/170959. eCollection 2023.
6
[Blocking Adenosine/A2AR Pathway for Cancer Therapy].[阻断腺苷/A2A受体通路用于癌症治疗]
Zhongguo Fei Ai Za Zhi. 2022 Jul 20;25(7):460-467. doi: 10.3779/j.issn.1009-3419.2022.102.24.
7
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.癌症中的 ATP 和腺苷代谢:治疗增益的探索。
Pharmacol Rev. 2022 Jul;74(3):797-822. doi: 10.1124/pharmrev.121.000528.
8
Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases.胰腺胆管疾病中的嘌呤能和腺苷能信号传导
Front Physiol. 2022 Mar 14;13:849258. doi: 10.3389/fphys.2022.849258. eCollection 2022.
9
Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon Tumors.弗林蛋白酶在结肠癌干细胞恶性表型以及KRAS和BRAF突变型结肠肿瘤中LGR5和NANOG表达中的作用
Cancers (Basel). 2022 Feb 25;14(5):1195. doi: 10.3390/cancers14051195.
10
Glioma Stem Cells Upregulate CD39 Expression to Escape Immune Response through SOX2 Modulation.胶质瘤干细胞通过SOX2调节上调CD39表达以逃避免疫反应。
Cancers (Basel). 2022 Feb 3;14(3):783. doi: 10.3390/cancers14030783.